References
- BC Centre for Excellence in HIV/AIDS. (2016). HIV monitoring quarterly report for British Columbia: Third quarter 2016. Retrieved from http://www.cfenet.ubc.ca/sites/default/files/uploads/publications/centredocs/bc_monitoring_report_16q3_final_nov-21.pdf
- BC Centre for Excellence in HIV/AIDS. (April 4, 2013). B.C. launches province-wide expansion of STOP HIV/AIDS® program. Retrieved from http://www.cfenet.ubc.ca/news/releases/bc-launches-province-wide-expansion-stop-hivaids-program
- BC Centre for Excellence in HIV/AIDS’ Committee for Drug Evaluation and Therapy. (2013). Therapeutic guidelines: Antiretroviral (ARV) treatment of adult HIV infection. Retrieved from http://www.cfenet.ubc.ca/therapeutic-guidelines
- Begley, K., McLaws, M. L., Ross, M. W., & Gold, J. (2008). Cognitive and behavioural correlates of non-adherence to HIV anti-retroviral therapy: Theoretical and practical insight for clinical psychology and health psychology. Clinical Psychologist, 12(1), 9–17. doi: 10.1080/13284200802069043
- Boyd, M. A. (2009). Improvements in antiretroviral therapy outcomes over calendar time. Current Opinion in HIV and AIDS, 4(3), 194–199. doi:10.1097/COH.0b013e328329fc8d . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19532050
- British Columbia Ministry of Justice, Adult Custody Division, & Corrections Branch. (2002). Health care services manual. Retrieved from http://docs.openinfo.gov.bc.ca/d37126413a_response_package_jag-2013-01023.pdf
- Cescon, A., Patterson, S., Davey, C., Ding, E., Raboud, J. M., Chan, K., … Collaboration, C. (2015). Late initiation of combination antiretroviral therapy in Canada: A call for a national public health strategy to improve engagement in HIV care. Journal of The international Aids Society, 18(1), 20024. doi:10.7448/IAS.18.1.20024 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26443752
- Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … Team, H. S. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365(6), pp. 493–505. doi:10.1056/NEJMoa1105243 . Retrieved from http://www.nejm.org/doi/pdf/10.1056/NEJMoa1105243
- Correctional Service Canada. (2015). Infectious disease surveillance in Canadian federal penitentiaries 2005-2006. Chapter 2: Human Immunodeficiency Virus (HIV). Retrieved from http://www.csc-scc.gc.ca/publications/infdscfp-2005-06/p5-eng.shtml
- Fehr, J., Nicca, D., Goffard, J. C., Haerry, D., Schlag, M., Papastamopoulos, V., … Ledergerber, B. (2016). Reasons for not starting antiretroviral therapy in HIV-1-infected individuals: A changing landscape. Infection, 44(4), 521–529. doi:10.1007/s15010-016-0887-x . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26983974
- Group, T. A. S., Danel, C., Moh, R., Gabillard, D., Badje, A., Le Carrou, J., … Anglaret, X. (2015). A trial of early antiretrovirals and isoniazid preventive therapy in Africa. New England Journal of Medicine, 373(9), 808–822. doi:10.1056/NEJMoa1507198 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26193126
- Hanna, D. B., Buchacz, K., Gebo, K. A., Hessol, N. A., Horberg, M. A., Jacobson, L. P., … Cohort, N. A. A. (2013). Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clinical Infectious Diseases, 56(8), 1174–1182. doi:10.1093/cid/cit003 . Retrieved from<Go to ISI>://WOS:000316700100023
- Hernandez Arroyo, M. J., Cabrera Figueroa, S. E., Sepulveda Correa, R., Valverde Merino, M. P., Luna Rodrigo, G., Dominguez-Gil Hurle, A., & Tormes, T. (2016). Influence of the number of daily pills and doses on adherence to antiretroviral treatment: A 7-year study. Journal of Clinical Pharmacy and Therapeutics, 41(1), 34–39. doi:10.1111/jcpt.12343 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26714444
- Johnson, M. O., Neilands, T. B., Dilworth, S. E., Morin, S. F., Remien, R. H., & Chesney, M. A. (2007). The role of self-efficacy in HIV treatment adherence: Validation of the HIV treatment Adherence Self-Efficacy Scale (HIV-ASES). Journal of Behavioral Medicine, 30(5), 359–370. doi:10.1007/s10865-007-9118-3 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17588200
- Joseph, B., Wood, E., Hayashi, K., Kerr, T., Barrios, R., Parashar, S., … Milloy, M. J. (2016). Factors associated with initiation of antiretroviral therapy among HIV-positive people who use injection drugs in a Canadian setting. AIDS, 30(6), pp. 925-932. doi:10.1097/QAD.0000000000000989 . Retrieved from<Go to ISI>://WOS:000371905500013
- Lee, J. H., Kim, G. J., Choi, B. S., Hong, K. J., Heo, M. K., Kim, S. S., & Kee, M. K. (2010). Increasing late diagnosis in HIV infection in South Korea: 2000-2007. BMC Public Health, 10, 411. doi:10.1186/1471-2458-10-411 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20624319
- Lima, V. D., Eyawo, O., Ma, H., Lourenco, L., Chau, W., Hogg, R. S., & Montaner, J. S. (2015). The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada. Journal of the International AIDS Society, 18, 20261. doi:10.7448/IAS.18.1.20261 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26449273
- Lima, V. D., Lourenco, L., Yip, B., Hogg, R. S., Phillips, P., & Montaner, J. S. G. (2015). Aids incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: A retrospective study. The Lancet HIV, 2(3), E92–E97. doi:10.1016/S2352-3018(15)00017-X . Retrieved from<Go to ISI>://WOS:000363792000008.
- Lima, V. D., Reuter, A., Harrigan, P. R., Lourenco, L., Chau, W., Hull, M., … Montaner, J. S. (2015). Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes. AIDS, 29(14), 1871–1882. doi:10.1097/QAD.0000000000000790 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26165354
- Lourenco, L., Colley, G., Nosyk, B., Shopin, D., Montaner, J. S., Lima, V. D., & Group, S. H. A. S. (2014). High levels of heterogeneity in the HIV cascade of care across different population subgroups in British Columbia, Canada. PLoS One, 9(12), e115277. doi:10.1371/journal.pone.0115277 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25541682
- Lourenco, L., Samji, H., Nohpal, A., Chau, W., Colley, G., Lepik, K., … Moore, D. M. (2015). Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada</=200 cells/muL and the contribution of diagnosis of HIV at CD4 cell counts </=200 cells/muL in British Columbia, Canada. HIV Medicine, 16(6), 337–345. doi:10.1111/hiv.12212 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25721157
- Insight Start Study Group, Lundgren, J. D., Babiker, A. G., Gordin, F., Emery, S., Grund, B., … Neaton, J. D. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV infection. New England Journal of Medicine, 373(9), pp. 795–807. doi:10.1056/NEJMoa1506816 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26192873
- Lundgren, J. D., Gatell, J. M., Rockstroh, J. K., & Furrer, H. (2015). EACS Guidelines Version 8.0. Retrieved from http://www.eacsociety.org/files/guidelines_8_0-english_web.pdf
- Margolis, A. M., Heverling, H., Pham, P. A., & Stolbach, A. (2014). A review of the toxicity of HIV medications. Journal of Medical Toxicology, 10(1), 26–39. doi:10.1007/s13181-013-0325-8 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23963694
- Milloy, M. J., Kerr, T., Buxton, J., Rhodes, T., Guillemi, S., Hogg, R., … Wood, E. (2011). Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. The Journal of Infectious Diseases, 203(9), 1215–1221. doi:10.1093/infdis/jir032 . Retrieved from<Go to ISI>://WOS:000289306100003
- Ndiaye, B., Salleron, J., Vincent, A., Bataille, P., Bonnevie, F., Choisy, P., … Yazdanpanah, Y. (2011). Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007. BMC Infectious Diseases, 11, 11. doi:10.1186/1471-2334-11-11 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21226905
- Newman, C. E., Mao, L. M., Persson, A., Holt, M., Slavin, S., Kidd, M. R., … de Wit, J. (2015). “Not until I'm absolutely half-dead and have To:” accounting for non-use of antiretroviral therapy in semi-structured interviews with people living with HIV in Australia. AIDS Patient Care and STDS, 29(5), pp. 267–278. doi:10.1089/apc.2014.0301 . Retrieved from<Go to ISI>://WOS:000353710600005
- Palmer, A. K., Cescon, A., Chan, K., Cooper, C., Raboud, J. M., Miller, C. L., … Collaboration, C. (2014). Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada. Journal of the International Association of Providers of AIDS Care (JIAPAC), 13(1), 56–62. doi:10.1177/2325957413510606 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24309754
- Solomon, D. A., & Sax, P. E. (2015). Current state and limitations of daily oral therapy for treatment. Current Opinion in Hiv and Aids, 10(4), 219–225. doi:10.1097/COH.0000000000000165 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26049945
- Takah, N. F., Awungafac, G., Aminde, L. N., Ali, I., Ndasi, J., & Njukeng, P. (2016). Delayed entry into HIV care after diagnosis in two specialized care and treatment centres in Cameroon: The influence of CD4 count and WHO staging. BMC Public Health, 16, 529. doi:10.1186/s12889-016-3258-8 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27390926
- Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., … Volberding, P. A. (2012). Antiretroviral treatment of adult HIV infection. JAMA, 308(4), 387–402. doi:10.1001/jama.2012.7961 . Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22820792
- Uijen, A. A., Heinst, C. W., Schellevis, F. G., van den Bosch, W. J., van de Laar, F. A., Terwee, C. B., & Schers, H. J. (2012). Measurement properties of questionnaires measuring continuity of care: A systematic review. PLoS One, 7(7), e42256. doi:10.1371/journal.pone.0042256. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22860100 doi: 10.1371/journal.pone.0042256
- Viswanathan, H., Aanderson, R., & Thomas, J. (2005). Evaluation of an antiretroviral medication attitude scale and relationships between medication attitudes and medication nonadherence. AIDS Patient Care and STDS, 19(5), 306–316. doi: 10.1089/Apc.2005.19.306 . Retrieved from<Go to ISI>://WOS:000229503400004
- World Health Organization. (2015). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Retrieved from http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf?ua=1